Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
06 Giugno 2023 - 1:00PM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology, today announced management
will participate in a fireside chat at the Goldman Sachs 44th
Annual Global Healthcare Conference on Tuesday, June 13,
2023, at 10:40 a.m. PT.
A live webcast of the fireside chat will be available on the
“Events & Presentations” page within the Investors section of
the Alector website at http://investors.alector.com. A replay
will be available on the Alector website for 90 days following the
event.
About AlectorAlector is a clinical-stage
biotechnology company pioneering immuno-neurology, a novel
therapeutic approach for the treatment of neurodegenerative
diseases. Immuno-neurology targets immune dysfunction as a root
cause of multiple pathologies that are drivers of degenerative
brain disorders. Alector has discovered and is developing a broad
portfolio of innate immune system programs, designed to
functionally repair genetic mutations that cause dysfunction of the
brain’s immune system and enable rejuvenated immune cells to
counteract emerging brain pathologies. Alector’s immuno-neurology
product candidates are supported by biomarkers and target
genetically defined patient populations in frontotemporal dementia
and Alzheimer’s disease. Alector is headquartered in South San
Francisco, California. For additional information, please visit
www.alector.com.
Alector Contacts:
AlectorKatie Hogan202-549-0557katie.hogan@alector.com
1AB (media)Dan Budwick973-271-6085 dan@1abmedia.com
Argot Partners (investors)Laura
Perry212.600.1902alector@argotpartners.com
Grafico Azioni Alector (NASDAQ:ALEC)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Alector (NASDAQ:ALEC)
Storico
Da Giu 2023 a Giu 2024